1. An appraisal of allergic disorders in India and an urgent call for action
- Author
-
Devasahayam J. Christopher, Padukudru Anand Mahesh, Mamidipudi Thirumala Krishna, Vinay Mehta, Pudupakkam K. Vedanthan, and Saibal Moitra
- Subjects
GDP, Gross Domestic Product ,Allergy ,NMBA, Neuromuscular blocking agents ,Gross domestic product ,0302 clinical medicine ,Continuing medical education ,DALY, Disability Associated Life Years ,Immunology and Allergy ,INR, Indian Rupees ,A&I, Allergy and Immunology ,030223 otorhinolaryngology ,USA, United States of America ,Functional illiteracy ,SLIT, Sublingual Immunotherapy ,education.field_of_study ,BTS, British Thoracic Society ,Atopic dermatitis ,Allergic bronchopulmonary aspergillosis ,CME, Continuing Medical Education ,Pulmonary and Respiratory Medicine ,lcsh:Immunologic diseases. Allergy ,USD, United States Dollars ,GINA, Global Initiative for Asthma ,ISAAC, International Study of Asthma and Allergies in Childhood ,AD, Atopic Dermatitis ,SAFS, Severe Asthma and Fungal Sensitisation ,Immunology ,Population ,IHDS, Indian Human Development Survey ,Article ,DBPCFC, Double Blind Placebo Controlled Food Challenge ,WHO, World Health Organization ,03 medical and health sciences ,Environmental health ,SCIT, Subcutaneous Injection Immunotherapy ,medicine ,ABPA, Allergic Bronchopulmonary Aspergillosis ,education ,AB-NHPS, Ayushman Bharath National Health Protection Scheme ,Asthma ,ELISA, Enzyme Linked Immunosorbent Assay ,PAFs, Population Attributable Factors ,business.industry ,COPD, Chronic Obstructive Pulmonary Disease ,ETS, Environmental Tobacco Smoke ,medicine.disease ,ICAAI, Indian College of Allergy Asthma and Applied Immunology ,030228 respiratory system ,SPT, Skin Prick Test ,business ,lcsh:RC581-607 - Abstract
India is the second most populous country in the world with a population of nearly 1.3 billion, comprising 20% of the global population. There are an estimated 37.5 million cases of asthma in India, and recent studies have reported a rise in prevalence of allergic rhinitis and asthma. Overall, 40–50% of paediatric asthma cases in India are uncontrolled or severe. Treatment of allergic rhinitis and asthma is sub-optimal in a significant proportion of cases due to multiple factors relating to unaffordability to buy medications, low national gross domestic product, religious beliefs, myths and stigma regarding chronic ailment, illiteracy, lack of allergy specialists, and lack of access to allergen-specific immunotherapy for allergic rhinitis and biologics for severe asthma. High quality allergen extracts for skin tests and adrenaline auto-injectors are currently not available in India. Higher postgraduate specialist training programmes in Allergy and Immunology are also not available. Another major challenge for the vast majority of the Indian population is an unacceptably high level of exposure to particulate matter (PM)2.5 generated from traffic pollution and use of fossil fuel and biomass fuel and burning of incense sticks and mosquito coils. This review provides an overview of the burden of allergic disorders in India. It appraises current evidence and justifies an urgent need for a strategic multipronged approach to enhance quality of care for allergic disorders. This may include creating an infrastructure for education and training of healthcare professionals and patients and involving regulatory authorities for making essential treatments accessible at subsidised prices. It calls for research into better phenotypic characterisation of allergic disorders, as evidence generated from high income western countries are not directly applicable to India, due to important confounders such as ethnicity, air pollution, high rates of parasitic infestation, and other infections.
- Published
- 2020